vimseltinib
deciphera,deciphera
['vimseltinib', 'deciphera']
$dcph deciphera pharmaceuticals, inc. presents updated phase 1/2 data for vimseltinib in tgct at the european society for medical oncology (esmo) congress 2022 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).